Cambridge Heart

Cambridge Heart, Inc. engages in the research, development, and commercialization of non-invasive diagnostic products for heart disease in the United States and internationally. The company offers the Heartwave II system for performing Microvolt T-Wave Alternans (MTWA) tests; the Micro-V Alternans Sensor, a multi-segment electrode for single-patient use in MTWA testing; and the CH2000 Cardiac Stress Testing System, a diagnostic system that supports various standard and physician-customized protocols for conducting and measuring cardiac exercise stress tests. It primarily markets and sells its products to cardiology group practices, physicians, hospitals, and research institutions. The company sells its products internationally through independent distributors.